About Biopta

Biopta Ltd was founded in 2002 by Dr David Bunton and Prof Chris Hillier with the vision to establish and maintain a dominant position as the worlds primary drug-tissue interaction specialists, based on quality and innovation in services and instrumentation.

Since 2002 Biopta has grown considerably. Over the last 6 years we have supported a number of global pharmaceutical and biotechnology companies and have expanded our expertise and services. In addition we have taken a new revolutionary concept and have grown this into our award wining platform technology, Perf-Exion and now offer services on our proprietary instrument PM-1. More information is available at Instruments.

We have unrivalled expertise in human tissue dissection and over 25 years experience in the area of in vitro pharmacology. This combined with our truly customer focussed service makes us a unique provider of in vitro pharmacology services and instruments.

Please contact us for further information, or e-mail us at info@biopta.com.